triamcinolone acetonide has been researched along with albuterol in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (41.18) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Farrar, JR; Feiss, G; Levy, S; Smith, JA; Welch, MJ | 1 |
| Duker, JS; Eliott, D; Gragoudas, ES; Haimovici, R; Sjaarda, RN | 1 |
| Ayars, GH; Berger, WE; Chervinsky, P; Condemi, JJ; Edwards, L; Ford, LB; Goldstein, MF; Pepsin, PJ; Rogenes, PR | 1 |
| Bernstein, DI; Cohen, R; Ginchansky, E; Pedinoff, AJ; Tinkelman, DG; Winder, JA | 1 |
| Baraniuk, J; Berger, WE; Edwards, LD; Johnson, M; Murray, JJ; Nathan, RA; Rickard, KA; Srebro, S | 1 |
| Banerji, D; Chervinsky, P; Jacobson, K; Kane, RE; Noonan, M; Uryniak, T | 1 |
| Banerji, D; Bernstein, D; Gross, G; Kane, RE; Welch, M | 1 |
| Lipworth, BJ | 1 |
| Cain, WT; Oppenheimer, JJ | 1 |
| Dorinsky, PM; Poinsett-Holmes, K; Stoloff, S | 1 |
| Boushey, HA; Fahy, JV; Kraft, M; Lazarus, SC; Lemanske, RF; Martin, RJ; Szefler, SJ | 1 |
| Eichelberger, MC; Ottolini, MG; Prince, GA | 1 |
| Larson, I; Morton, DA; Qu, L; Stewart, PJ; Zhou, QT | 1 |
| Buckton, G; Jones, MD | 1 |
1 review(s) available for triamcinolone acetonide and albuterol
| Article | Year |
|---|---|
Combination therapy with inhaled long-acting beta2-agonists and inhaled corticosteroids: a paradigm shift in asthma management.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Albuterol; Androstadienes; Anti-Inflammatory Agents; Asthma; Bronchodilator Agents; Budesonide; Cost-Benefit Analysis; Drug Therapy, Combination; Fluticasone; Humans; Leukotriene Antagonists; Salmeterol Xinafoate; Triamcinolone Acetonide | 2002 |
8 trial(s) available for triamcinolone acetonide and albuterol
| Article | Year |
|---|---|
Dose-ranging study of the clinical efficacy of twice-daily triamcinolone acetonide inhalation aerosol in moderately severe asthma.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Aerosols; Albuterol; Anti-Inflammatory Agents; Asthma; Bronchodilator Agents; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Evaluation Studies as Topic; Female; Forced Expiratory Volume; Glucocorticoids; Humans; Incidence; Linear Models; Male; Middle Aged; Peak Expiratory Flow Rate; Pharyngitis; Placebos; Time Factors; Triamcinolone Acetonide | 1997 |
Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosols; Aged; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Child; Chronic Disease; Double-Blind Method; Female; Fluticasone; Forced Expiratory Volume; Glucocorticoids; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Placebos; Powders; Triamcinolone Acetonide | 1997 |
A multicenter, placebo-controlled study of twice daily triamcinolone acetonide (800 microg per day) for the treatment of patients with mild-to-moderate asthma.
Topics: Adult; Albuterol; Anti-Inflammatory Agents; Asthma; Double-Blind Method; Drug Administration Schedule; Female; Humans; Lung; Male; Maximal Expiratory Flow Rate; Middle Aged; Triamcinolone Acetonide | 1998 |
Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma.
Topics: Administration, Inhalation; Administration, Topical; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Bronchodilator Agents; Child; Double-Blind Method; Drug Therapy, Combination; Female; Fluticasone; Forced Expiratory Volume; Glucocorticoids; Humans; Male; Middle Aged; Peak Expiratory Flow Rate; Salmeterol Xinafoate; Sleep; Triamcinolone Acetonide | 1999 |
Placebo-controlled, comparative study of the efficacy and safety of triamcinolone acetonide inhalation aerosol with the non-CFC propellant HFA-134a in patients with asthma. Azmacort HFA Clinical Study Group.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosol Propellants; Aerosols; Aged; Albuterol; Anti-Asthmatic Agents; Asthma; Chlorofluorocarbons; Double-Blind Method; Drug Therapy, Combination; Forced Expiratory Volume; Glucocorticoids; Humans; Hydrocarbons, Fluorinated; Male; Middle Aged; Safety; Treatment Outcome; Triamcinolone Acetonide | 1999 |
A controlled trial of chlorofluorocarbon-free triamcinolone acetonide inhalation aerosol in the treatment of adult patients with persistent asthma. Azmacort HFA Study Group.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosol Propellants; Aged; Albuterol; Asthma; Bronchodilator Agents; Chlorofluorocarbons, Methane; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Forced Expiratory Volume; Glucocorticoids; Humans; Hydrocarbons, Fluorinated; Male; Middle Aged; Peak Expiratory Flow Rate; Safety; Treatment Outcome; Triamcinolone Acetonide | 1999 |
Use of fluticasone in asthma.
Topics: Administration, Inhalation; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bias; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Fluticasone; Humans; Research Design; Salmeterol Xinafoate; Triamcinolone Acetonide | 2000 |
Airway tissue mast cells in persistent asthma: predictor of treatment failure when patients discontinue inhaled corticosteroids.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Anti-Inflammatory Agents; Asthma; Biopsy; Bronchoalveolar Lavage Fluid; Bronchoscopy; Cell Count; Double-Blind Method; Female; Humans; Inflammation Mediators; Male; Mast Cells; Salmeterol Xinafoate; Serine Endopeptidases; Time Factors; Treatment Failure; Triamcinolone Acetonide; Tryptases | 2003 |
8 other study(ies) available for triamcinolone acetonide and albuterol
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Androstadienes; Asthma; Beclomethasone; Bronchitis; Choroid Diseases; Exudates and Transudates; Female; Fluorescein Angiography; Fluticasone; Fundus Oculi; Glucocorticoids; Humans; Male; Middle Aged; Pigment Epithelium of Eye; Prospective Studies; Retinal Detachment; Retinal Diseases; Rhinitis; Risk Factors; Triamcinolone Acetonide; Visual Acuity | 1997 |
The misconception of using floating patterns as an accurate means of measuring the contents of metered-dose inhaler devices.
Topics: Albuterol; Androstadienes; Anti-Inflammatory Agents; Drug Delivery Systems; Fluticasone; Nebulizers and Vaporizers; Reproducibility of Results; Triamcinolone Acetonide; Water | 2001 |
Influenza-induced tachypnea is prevented in immune cotton rats, but cannot be treated with an anti-inflammatory steroid or a neuraminidase inhibitor.
Topics: Albuterol; Animals; Anti-Inflammatory Agents; Antiviral Agents; Bronchodilator Agents; Disease Models, Animal; Female; Glucocorticoids; Guanidines; Humans; Influenza A virus; Influenza, Human; Male; Neuraminidase; Pyrans; Respiration Disorders; Sialic Acids; Sigmodontinae; Triamcinolone Acetonide; Zanamivir | 2004 |
Improving aerosolization of drug powders by reducing powder intrinsic cohesion via a mechanical dry coating approach.
Topics: Administration, Inhalation; Aerosols; Albuterol; Chemistry, Pharmaceutical; Excipients; Nebulizers and Vaporizers; Particle Size; Powders; Salmeterol Xinafoate; Stearic Acids; Triamcinolone Acetonide | 2010 |
Comparison of the cohesion-adhesion balance approach to colloidal probe atomic force microscopy and the measurement of Hansen partial solubility parameters by inverse gas chromatography for the prediction of dry powder inhalation performance.
Topics: Adhesiveness; Administration, Inhalation; Albuterol; Beclomethasone; Budesonide; Chemistry, Pharmaceutical; Chromatography, Gas; Colloids; Drug Carriers; Dry Powder Inhalers; Erythritol; Lactose; Mannitol; Microscopy, Atomic Force; Particle Size; Pharmaceutical Preparations; Powders; Solubility; Terbutaline; Triamcinolone Acetonide | 2016 |